Indian-American scientist Vinay Prasad has stepped down for the second time as director of the FDA’s Center for Biologics Evaluation and Research within a year. His tenure saw record approvals but also sharp disputes with pharmaceutical companies, including Moderna and UniQure, over trial standards.
The study, led by researchers at the India Energy and Climate Center (IECC) at the University of California (UC) Berkeley, US, highlighted that India adds 10-15 million new ACs annually, with another 130-150 million expected over the next decade.
New York: About a quarter of the world’s Internet users live in countries that are more susceptible than previously thought to targeted attacks on their Internet infrastructure, find researchers. The structure of the Internet can differ dramatically in different parts of the world. According to computer scientists at the University of California San Diego, who […]
The new study titled, 'Glucagon regulates the stability of REV-ERBa to modulate hepatic glucose production in a model of lung cancer-associated cachexia', was published in the journal Science Advances.
